7T HR FID-MRSI Compared to Amino Acid PET: Glutamine and Glycine as Promising Biomarkers in Brain Tumors
Authors:
- Gilbert HangelGHGilbert Hangel
- Philipp LazenPLPhilipp Lazen
- Sukrit SharmaSSSukrit Sharma
- Barbara HristoskaBHBarbara Hristoska
- Cornelius CadrienCCCornelius Cadrien
- Julia FurtnerJulia Furtner
- Ivo RauschIRIvo Rausch
- Alexandra LipkaALAlexandra Lipka
- Eva NiessENEva Niess
- Lukas HingerlLHLukas Hingerl
- Stanislav MotykaSMStanislav Motyka
- Stephan GruberSGStephan Gruber
Open Access
Abstract
(1) Background: Recent developments in 7T magnetic resonance spectroscopic imaging (MRSI) made the acquisition of high-resolution metabolic images in clinically feasible measurement times possible. The amino acids glutamine (Gln) and glycine (Gly) were identified as potential neuro-oncological markers of importance. For the first time, we compared 7T MRSI to amino acid PET in a cohort of glioma patients. (2) Methods: In 24 patients, we co-registered 7T MRSI and routine PET and compared hotspot volumes of interest (VOI). We evaluated dice similarity coefficients (DSC), volume, center of intensity distance (CoI), median and threshold values for VOIs of PET and ratios of total choline (tCho), Gln, Gly, myo-inositol (Ins) to total N-acetylaspartate (tNAA) or total creatine (tCr). (3) Results: We found that Gln and Gly ratios generally resulted in a higher correspondence to PET than tCho. Using cutoffs of 1.6-times median values of a control region, DSCs to PET were 0.53 ± 0.36 for tCho/tNAA, 0.66 ± 0.40 for Gln/tNAA, 0.57 ± 0.36 for Gly/tNAA, and 0.38 ± 0.31 for Ins/tNAA. (4) Conclusions: Our 7T MRSI data corresponded better to PET than previous studies at lower fields. Our results for Gln and Gly highlight the importance of future research (e.g., using Gln PET tracers) into the role of both amino acids.Keywords
Funding Information
- the Austrian Science Fund (FWF) (KLI 646, P 30701, and P 34198)
This publication has 47 references indexed in Scilit:
- Metabolic Mapping of Gliomas Using Hybrid MR-PET ImagingInvestigative Radiology, 2013
- Performance of 18F-Fluoro-Ethyl-Tyrosine (18F-FET) PET for the Differential Diagnosis of Primary Brain Tumor: A Systematic Review and MetaanalysisJournal of Nuclear Medicine, 2012
- Detection of 2-Hydroxyglutarate in IDH -Mutated Glioma Patients by In Vivo Spectral-Editing and 2D Correlation Magnetic Resonance SpectroscopyScience Translational Medicine, 2012
- High‐resolution mapping of human brain metabolites by free induction decay 1H MRSI at 7 TNMR in Biomedicine, 2011
- 7‐T MR—from research to clinical applications?NMR in Biomedicine, 2011
- In vivo metabolic profiling of glioma‐initiating cells using proton magnetic resonance spectroscopy at 14.1 TeslaNMR in Biomedicine, 2011
- 1H MR spectroscopy of inflammation, infection and ischemia of the brainEuropean Journal of Radiology, 2008
- Metabolic Imaging of Cerebral Gliomas: Spatial Correlation of Changes in O-(2-18F-Fluoroethyl)-l-Tyrosine PET and Proton Magnetic Resonance Spectroscopic ImagingJournal of Nuclear Medicine, 2008
- Metabolic Assessment of Gliomas Using11C-Methionine, [18F] Fluorodeoxyglucose, and11C-Choline Positron-Emission TomographyAmerican Journal of Neuroradiology, 2008
- Identification of human brain tumour initiating cellsNature, 2004